Navigation Links
Unigen Announces the Launch of Nivitol™ - Powerful New Anti-Aging Skin Care Ingredient
Date:5/7/2010

Unigen, Inc®, announces the launch of Nivitol™, a revolutionary breakthrough botanical anti-aging skin care ingredient. Unigen® has entered into multiple global license and supply agreements for Nivitol™ with some of the world's premiere manufacturers and marketers of quality skin care, makeup, fragrance and hair care products.

(PRWEB) May 7, 2010 -- Unigen, Inc®, announces the launch of Nivitol™, a revolutionary breakthrough botanical anti-aging skin care ingredient. Unigen® has entered into multiple global license and supply agreements for Nivitol™ with some of the world's premiere manufacturers and marketers of quality skin care, makeup, fragrance and hair care products.

Nivitol™ is a natural botanical alternative, derived from the novel plant extract Dianella ensifolia, and has been scientifically proven to visibly improve skin appearance. Nivitol™ contains a unique enzyme-blocking, or tyrosinase-inhibiting, agent that reduces skin pigmentation and safely lightens skin color without any adverse side effects often found with harsh chemicals. Clinical studies have shown Nivitol™ to be up to 20x more effective than the leading whitening agents such as hydroquinone and kojic acid. It has been thoroughly safety tested by independent third party institutes and has shown no adverse side effects. Additionally, Nivitol™ is extremely potent and can be effectively used at 10-50x lower concentrations than competitive whitening agents making it a cost-effective alternative. It is highly compatible in formulation with other skin care ingredients and can be used as an active agent in creams, lotions, gels, masks and other cosmetic products.

Pat Schneider, Unigen’s Chief Business Officer is extremely upbeat about the opportunities for Nivitol™. “The market for skin whitening, brightening and lightening is $9.8B strong and growing.” said Schneider. Over the last 5 years, this interest has spread to Europe and the US as part of a worldwide anti-aging trend and growing consumer demand for products that reduce dark spots and provide an “even tone” or “tone correcting” benefit resulting in more youthful looking skin.

“We are very excited to be working with several forward thinking giants in the cosmetic industry to provide safe, novel botanical ingredients like Nivitol™ and help develop superior anti-aging products” commented Schneider. Unigen’s scientific expertise in researching and discovering patented, clinically effective, natural ingredients has made significant advancements in the development of next generation skin care products.    Schneider added, “Nivitol™ is taking skin care science to the next level. With more new advancements in development, Unigen® will continue to be a leader in providing cutting edge ingredients that have the potential to positively affect the lives of millions.”

About Unigen
Unigen, Inc. is a global leader in the discovery and development of proprietary natural ingredients for the dietary supplement, food, cosmetics, personal care and pharmaceutical industries. The company has one of the most extensive medicinal plant collections in the world and utilizes a state-of-the-art pharmaceutical discovery approach to identify the most safe and effective botanically-based proprietary ingredients. The efficacy of Unigen’s natural product ingredients is established through human clinical trials, and unlike synthetic drugs, Unigen’s natural substances have a legacy of safe human consumption without the undesirable side-effects that limit the use of pharmaceuticals. Unigen protects its discoveries through patents and commercializes its products through alliances with partners that possess distribution and marketing capabilities in each of Unigen’s target markets.    

###

Read the full story at http://www.prweb.com/releases/2010/05/prweb3969324.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Unigene Restates Policy on Analyst Reports
2. Stonegate Report About Unigene Laboratories Inc.
3. China Sky One Medical Announces Conference Call to Discuss First Quarter 2010 Results
4. Crucell Announces New Award of $110 Million for Paediatric Vaccine Quinvaxem(R) by UNICEF to Support Vaccination Programs in the Developing World
5. Healthcare Data Solutions Announces New Executive Team Member
6. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
7. Romark Announces Final Data From Clinical Trial of Nitazoxanide in Treatment-Naive Patients With Genotype 1 Chronic Hepatitis C
8. Angiotech announces exclusive distribution agreement with B. Braun for Angiotechs proprietary Quill(TM) SRS product line
9. PolyTouch Medical Ltd. Announces the Submission of a Premarket Application for PatchAssist - an Innovative Mesh Deployment and Placement Device for Laparoscopic Hernia Repair
10. Pieris Announces Positive Preclinical Data on c-Met Anticalin Drug Program
11. Scotland Announces New Life Science Leadership and Investments at BIO 2010
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Unigen Announces the Launch of Nivitol™ - Powerful New Anti-Aging Skin Care Ingredient 
(Date:6/27/2016)... - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces ... Clean Technology Fund I, LP and Clean Technology Fund ... venture capital funds which together hold approximately 59% of ... as converted basis), that they have entered into an ... in Biorem to TUS Holdings Co. Ltd. ("TUS") (en.tusholdings.com) ...
(Date:6/27/2016)... N.C. (PRWEB) , ... June 27, 2016 , ... ... commercial operations for Amgen, will join the faculty of the University of ... as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... area for financial services, but it also plays a fundamental ...
(Date:4/26/2016)... 27, 2016 Research and ... Biometrics Market 2016-2020"  report to their offering.  , ... The analysts forecast the global multimodal biometrics ... during the period 2016-2020.  Multimodal biometrics ... such as the healthcare, BFSI, transportation, automotive, and ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
Breaking Biology News(10 mins):